BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6363750)

  • 1. [Factors in the development of Kawasaki disease and specificity of immunity in children].
    Matsuoka Y; Yata J
    Nihon Rinsho; 1983 Sep; 41(9):2047-51. PubMed ID: 6363750
    [No Abstract]   [Full Text] [Related]  

  • 2. Kawasaki disease.
    Samuel J; O'Sullivan J
    Br J Hosp Med; 1996 Jan 17-Feb 6; 55(1-2):9-14. PubMed ID: 8646401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent mucocutaneous lymph node syndrome (Kawasaki disease): a report of three cases.
    Keren G; Passwell J; Cohen BE
    J Med; 1986; 17(5-6):365-71. PubMed ID: 3473170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic abnormalities in Kawasaki syndrome.
    Leung DY
    Prog Clin Biol Res; 1987; 250():159-65. PubMed ID: 3501125
    [No Abstract]   [Full Text] [Related]  

  • 5. [Imbalance among circulating T cell subsets and staining for HLA-DR antigen in coronary endothelial cells in Kawasaki disease].
    Terai M; Kohno Y; Niwa K; Umemiya T; Mikata A; Nakajima H
    Arerugi; 1987 Jul; 36(7):394-403. PubMed ID: 3500695
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome.
    Leung DY; Chu ET; Wood N; Grady S; Meade R; Geha RS
    J Immunol; 1983 May; 130(5):2002-4. PubMed ID: 6220072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenesis of Kawasaki disease and superantigens.
    Uchiyama T; Kato H
    Jpn J Infect Dis; 1999 Aug; 52(4):141-5. PubMed ID: 10592892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte subpopulations in Kawasaki disease.
    Shannon K; Fink CW; Buchanan GR; Punaro M; Stastny P
    Clin Exp Rheumatol; 1983; 1(1):59-62. PubMed ID: 6398155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of Kawasaki disease and the initial infection by EB virus].
    Kikuta H; Mizuno F; Osato T; Konno M; Ishikawa N; Nanbu H; Anakura M; Oka Y; Matsumoto S; Noro S
    Nihon Rinsho; 1983 Sep; 41(9):2069-74. PubMed ID: 6319775
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of Kawasaki syndrome by intravenous gamma globulins. A medium-term clinical and paraclinical study of 5 cases].
    Lebranchu Y; Despert F; Borderon JC; Bloc D; Renoux M; Bardos P; Laugier J
    Ann Pediatr (Paris); 1986 Nov; 33(9):809-13. PubMed ID: 3492169
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evidence for a possible role of the mite antigen in Kawasaki disease].
    Furusho K; Sato K; Soeda T; Okabe T; Hirota T
    Nihon Rinsho; 1983 Sep; 41(9):2017-22. PubMed ID: 6229653
    [No Abstract]   [Full Text] [Related]  

  • 12. The immunopathogenesis and management of Kawasaki syndrome.
    Leung DY; Schlievert PM; Meissner HC
    Arthritis Rheum; 1998 Sep; 41(9):1538-47. PubMed ID: 9751085
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune complexes in Kawasaki syndrome: a review.
    Pachman LM; Herold BC; Davis AT; Hang LM; Schaller JG; Beckwith B; Arroyave CM; Gawryl MS; Lint T; Shulman ST
    Prog Clin Biol Res; 1987; 250():193-207. PubMed ID: 3321076
    [No Abstract]   [Full Text] [Related]  

  • 14. Spirochaetal studies in Kawasaki syndrome.
    Marchette NJ; Melish ME; James JF; Kihara S; Caplan F
    Prog Clin Biol Res; 1987; 250():87-99. PubMed ID: 3423085
    [No Abstract]   [Full Text] [Related]  

  • 15. Epstein-Barr virus-specific cytotoxic T lymphocyte (EBV-CTL) activities in patients with Kawasaki syndrome.
    Shinohara K; Katsuki T; Koike M
    Prog Clin Biol Res; 1987; 250():569-70. PubMed ID: 2827182
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study on the etiology of Kawasaki disease based on the changes in symptomatology and morbidity among various age groups--on validity of the streptococcal infection theory].
    Yamamoto T
    Nihon Rinsho; 1983 Sep; 41(9):1994-2004. PubMed ID: 6663737
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study on peripheral blood mononuclear cell subpopulations in children. Part II. Peripheral blood mononuclear cell subpopulations in patients with Kawasaki disease].
    Ogiwara A
    Arerugi; 1984 Jul; 33(7):369-75. PubMed ID: 6497666
    [No Abstract]   [Full Text] [Related]  

  • 18. [Autoantibodies in patients with mucocutaneous lymph node syndrome (Kawasaki disease)].
    Saji T; Umezawa T; Hashiguchi R; Matsuo N
    Arerugi; 1983 Dec; 32(12):1129-33. PubMed ID: 6678147
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum anti-Yersinia antibody in Chinese patients with Kawasaki disease.
    Chou CT; Chang JS; Ooi SE; Huo AP; Chang SJ; Chang HN; Tsai CY
    Arch Med Res; 2005; 36(1):14-8. PubMed ID: 15777989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mucocutaneous lymph node syndrome (Kawasaki disease). Presentation of 3 cases].
    Hernández Lorca A; Bentiez Rubio MR; García Santiago M; Hernández Delgado J; García Suárez E; González Mediero I; Silgo Pujalte M; García Pérez J
    An Esp Pediatr; 1983 Jul; 19(1):59-64. PubMed ID: 6638713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.